Predictive model for carbapenem-resistant Klebsiella pneumoniae bloodstream infection based on a nomogram: a
Jiahao Guan1, Yajuan Ren2, Xiaojun Dang1
1Department of Clinical Laboratory, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Objective:
Carbapenem-resistant Klebsiella pneumoniae bloodstream infections (BSIs-CRKP) are associated with high mortality rates, necessitating early risk stratification tools. This study aimed to identify risk factors and develop a nomogram model to predict BSIs-CRKP in hospitalized patients. A single-center retrospective case-control study was conducted at Shaanxi Provincial People's Hospital (2017-2024). Patients with Klebsiella pneumoniae bacteremia were stratified into CRKP (n = 154) and carbapenem-susceptible (CSKP, n = 233) groups. Clinical data, including demographics, comorbidities, treatments, and antimicrobial exposure, were analyzed. Risk factors were identified via multivariate logistic regression, and a nomogram model was developed using R software. Model performance was evaluated using ROC curves, calibration plots, and the Hosmer-Lemeshow test.
Results:
Independent risk factors for BSIs-CRKP included indwelling urinary catheterization (OR = 2.531, P = 0.038), central venous catheterization (OR = 2.673, P = 0.015), immunosuppressant use (OR = 3.782, P = 0.006), carbapenem exposure (OR = 4.470, P < 0.001), and age ≥ 65 years (OR = 3.740, P = 0.002). A nomogram model was constructed based on these risk factors, which demonstrated good predictive performance with an area under the curve (AUC) of 0.878 (95% CI: 0.845-0.910) and exhibited excellent calibration (Hosmer-Lemeshow, P = 0.234). This nomogram model effectively stratifies BSIs-CRKP risk using five clinically accessible variables. External validation and integration of genomic data are warranted to enhance generalizability and precision.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Two-Compartment Open Model: Extravascular Administration
The absorption exponent (ka) indicates the speed at which the drug...


